Informed Consent
Item
informed consent signed (appendix a)
boolean
C0021430 (UMLS CUI [1])
Gender | Adult | Age
Item
adult men greater than 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001675 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Adenocarcinoma of prostate
Item
histologically confirmed diagnosis of adenocarcinoma of the prostate (centrally reviewed).
boolean
C0007112 (UMLS CUI [1])
TNM clinical staging | Gleason score | Prostate specific antigen measurement
Item
clinical stage t1-t2b, gleason score < 6, and psa < 10 ng/ml
boolean
C3258246 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
Biopsy Percentage Positive Malignant Neoplasms
Item
less than 50% of biopsy cores +ve for cancer
boolean
C0005558 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C0006826 (UMLS CUI [1,4])
Body Surface Area Percentage Involvement with Malignant Neoplasms
Item
less than 50% overall surface area involved with cancer
boolean
C0005902 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0006826 (UMLS CUI [1,4])
Hormone suppression therapy Neoadjuvant | Prostate specific antigen measurement | Androgen suppression | Luteinizing Hormone-releasing Hormone Agonist | Therapeutic radiology procedure Planned
Item
neoadjuvant hormone suppression therapy is allowed. however, psa, must have been performed within 2 months of starting androgen suppression therapy. if androgen suppression therapy has been started lhrh agonist must be continued for a minimum of 3 months before initiation of gold fiducial marker insertion & radiotherapy planning.
boolean
C1535931 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C1515985 (UMLS CUI [3])
C1518041 (UMLS CUI [4])
C1522449 (UMLS CUI [5,1])
C1301732 (UMLS CUI [5,2])
Radiotherapy to pelvis
Item
prior pelvic radiotherapy.
boolean
C1536155 (UMLS CUI [1])
Anticoagulants
Item
concurrent anticoagulation medication (if it is unsafe to discontinue for gold seed insertion)
boolean
C0003280 (UMLS CUI [1])
Bleeding tendency
Item
diagnosis of bleeding diathesis
boolean
C1458140 (UMLS CUI [1])
Hip Prosthesis
Item
presence of a hip prosthesis
boolean
C0019560 (UMLS CUI [1])
Pelvis Measurement of girth
Item
pelvic girth >40cm (to ensure visibility of gold seeds on electronic portal imaging device)
boolean
C0030797 (UMLS CUI [1,1])
C0203911 (UMLS CUI [1,2])
Large prostate Imaging
Item
large prostate (> 60 cm3) on imaging
boolean
C0426732 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
Lower Urinary Tract Symptoms Severe International prostate symptom score | Nocturia
Item
severe lower urinary tract symptoms (international prostate symptom score > 15 or nocturia > 3)
boolean
C0574785 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1998280 (UMLS CUI [1,3])
C0028734 (UMLS CUI [2])